The present invention relates to a method for increasing efficacy and/orpossibility of therapeutic treatment of cancer, wherein any dys-regulatorymechanism, including inducing factor/s, of the production of immunoregulatorysubstances, including one or more cytokines, including IL-1.beta., IL-1Ra, IL-6, IL-10, IL-17, TNF-.alpha., and others, is therapeutically controlled tominimise pathological production of such immunoregulatory substances, toenhance the therapeutic control of a malignant tumour in a subject sufferingfrom a cancer, a method for analysing dys-regulatory mechanism controllingsubstances, kit for such analysis, use of certain compounds for preparingpharmaceutical preparations, and pharmaceutical preparations.
